CLYM
Price
$4.93
Change
+$0.08 (+1.65%)
Updated
Dec 26 closing price
Capitalization
330.69M
72 days until earnings call
Intraday BUY SELL Signals
KYTX
Price
$9.40
Change
+$0.41 (+4.56%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
535.86M
Intraday BUY SELL Signals
Interact to see
Advertisement

CLYM vs KYTX

Header iconCLYM vs KYTX Comparison
Open Charts CLYM vs KYTXBanner chart's image
Climb Bio
Price$4.93
Change+$0.08 (+1.65%)
Volume$774.64K
Capitalization330.69M
Kyverna Therapeutics
Price$9.40
Change+$0.41 (+4.56%)
Volume$13.41K
Capitalization535.86M
CLYM vs KYTX Comparison Chart in %
CLYM
Daily Signal:
Gain/Loss:
KYTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLYM vs. KYTX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYM is a Buy and KYTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (CLYM: $4.85 vs. KYTX: $8.99)
Brand notoriety: CLYM and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYM: 23% vs. KYTX: 53%
Market capitalization -- CLYM: $330.69M vs. KYTX: $535.86M
CLYM [@Biotechnology] is valued at $330.69M. KYTX’s [@Biotechnology] market capitalization is $535.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYM’s FA Score shows that 1 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • CLYM’s FA Score: 1 green, 4 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CLYM is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 5 TA indicator(s) are bullish while KYTX’s TA Score has 5 bullish TA indicator(s).

  • CLYM’s TA Score: 5 bullish, 5 bearish.
  • KYTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KYTX is a better buy in the short-term than CLYM.

Price Growth

CLYM (@Biotechnology) experienced а +14.12% price change this week, while KYTX (@Biotechnology) price change was +30.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.37%. For the same industry, the average monthly price growth was +0.28%, and the average quarterly price growth was +55.43%.

Reported Earning Dates

CLYM is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (+0.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($536M) has a higher market cap than CLYM($331M). CLYM YTD gains are higher at: 169.444 vs. KYTX (140.374). CLYM has higher annual earnings (EBITDA): -59.5M vs. KYTX (-158.93M). KYTX has more cash in the bank: 171M vs. CLYM (86.9M). CLYM has less debt than KYTX: CLYM (580K) vs KYTX (5.02M). CLYM (0) and KYTX (0) have equivalent revenues.
CLYMKYTXCLYM / KYTX
Capitalization331M536M62%
EBITDA-59.5M-158.93M37%
Gain YTD169.444140.374121%
P/E RatioN/AN/A-
Revenue00-
Total Cash86.9M171M51%
Total Debt580K5.02M12%
TECHNICAL ANALYSIS
Technical Analysis
CLYMKYTX
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLYM
Daily Signal:
Gain/Loss:
KYTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRCEX27.310.16
+0.59%
Principal Real Estate Securities C
HADAX29.510.07
+0.24%
Hartford Balanced HLS IA
PAHUX7.32N/A
N/A
PGIM Jennison NextGeneration Glb Opps Z
LICPX18.05-0.01
-0.06%
Lord Abbett International Equity P
GCINX16.20-0.01
-0.06%
Green Century MSCI Intl Indx Indvl Inv

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with KYTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
+5.43%
KYTX - CLYM
43%
Loosely correlated
+1.24%
IMVT - CLYM
39%
Loosely correlated
+0.45%
VYGR - CLYM
35%
Loosely correlated
+2.01%
ABOS - CLYM
35%
Loosely correlated
-0.46%
RGNX - CLYM
34%
Loosely correlated
+0.77%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with CLYM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then CLYM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
+1.24%
CLYM - KYTX
44%
Loosely correlated
+5.43%
VTGN - KYTX
44%
Loosely correlated
+2.08%
HOWL - KYTX
40%
Loosely correlated
+5.04%
IMNM - KYTX
40%
Loosely correlated
+2.76%
FDMT - KYTX
40%
Loosely correlated
+2.53%
More